SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that DefenCath reimbursement could decline sharply through 2027 has fueled concern about pricing and CorMedixs largest revenue driver. Traders are divided: some see a lasting revenue risk, while others argue DaVitas estimate is preliminary and not a definitive forecast of CMS rates or CorMedix revenue.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Ciscos decline is being tied to an analyst price-target cut amid concerns that networking growth may be peaking and the stocks valuation could compress; the firm kept its rating unchanged. Traders are split between calling the selloff an overreaction given AI-networking demand and seeing continued technical weakness.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A breakout to a fresh 52-week high has traders focused on anticipated Q3 earnings and BRIUMVIs growth, with buyout speculation and possible short covering adding to the bullish momentum. Some traders see the move as earnings-driven, while others caution that takeover talk remains unconfirmed.

First Majestic Silver Corp. engages in the production, development, exploration, and acquisition of mineral properties, with a focus on silver and gold production in North America. It owns and operates producing mines in Mexico, including the Santa Elena Silver & Gold Mine, the Los Gatos Silver Mine, the San Dimas Silver & Gold Mine, and the La Encantada Silver Mine. It also owns the Jerritt Canyon Gold Mine in Nevada, USA, which is currently in the process of restarting. The company was founded by Keith Neumeyer on September 26, 1979 and is headquartered in Vancouver, Canada.

First Majestic Silver Corporation

AG is drawing attention amid volatile silver prices and weakness across precious-metals miners, with traders pointing to rising yields and expectations of tighter Fed policy as headwinds. Some see the pullback as a buying opportunity based on long-term silver supply and demand, while others expect further downside and question when miners will recover.

BNB (BNB) is a cryptocurrency . BNB has a current supply of 131,511,387.69. The last known price of BNB is 703.59425696 USD and is up 0.47 over the last 24 hours. It is currently trading on 3523 active market(s) with $2,735,089,335.64 traded over the last 24 hours. More information can be found at https://bnbchain.org/en.

Binance

A reported multibillion-dollar Binance security breach is driving attention, with traders focused on suspended withdrawals and concerns about exchange security and customer funds. The community debates whether Binance can cover the losses and whether BNBs limited decline understates the risk; claims of an inside job or specific perpetrators remain speculation.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disney is drawing attention for choppy trading around technical resistance, with traders split on whether a breakout can hold or shares will retreat toward support. Bullish options activity and optimism about parks, streaming and recent earnings compete with frustration over the stocks long-term performance.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Reported Lundbeck interest in acquiring Xeris has fueled takeover speculation, with traders debating whether other buyers could emerge; the company has said it is not for sale, and no deal is confirmed. Others are focused on the upcoming quarterly results and Recorlev growth, as well as the longer-term XP-8121 Phase 3 opportunity.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

Attention centers on upcoming CRISPR Therapeutics updates, especially CTX310 Phase 1b data and zugo-cel results, alongside earnings and Casgevy sales. Traders are divided between optimism about the clinical catalysts and frustration over the stocks persistent weakness and rangebound trading.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Positive Phase 3 results for Amgens IMDELLTRAImfinzi combination in small-cell lung cancer are driving attention, with traders pointing to the survival benefit as support for the companys oncology pipeline and recent strength. The discussion is also focused on momentum near 52-week highs ahead of quarterly results and an upcoming Sjgrens disease data presentation.

Pudgy Penguins (PENGU) is a cryptocurrency launched in 2024and operates on the Solana platform. Pudgy Penguins has a current supply of 76,724,221,264.3 with 62,860,396,090.04 in circulation. The last known price of Pudgy Penguins is 0.00754361 USD and is up 6.59 over the last 24 hours. It is currently trading on 540 active market(s) with $130,377,930.32 traded over the last 24 hours. More information can be found at https://www.pengu.pudgypenguins.com.

Pudgy Penguins

Traders are focused on PENGU testing a technical support/buying zone after rejection from a descending channel, debating whether it can bounce or break lower. Some are buying the dip and anticipating a reversal, while others warn of further downside; broader crypto moves, especially Bitcoin, are also seen as influential.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BG Q3 Earnings Beat on Strong Soybean and Softseed Results

Bunge's Q3 earnings beat estimates as strong soybean and softseed processing boosted profits, while weaker segments weighed on results. The company maintained its 2026 earnings outlook.

Bunge Global Q3 2026 Earnings Call Transcript

Bunge Global (NYSE:BG) reported third-quarter financial results on Thursday. The transcript from the company's third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. Forread more...

Compared to Estimates, Bunge Global (BG) Q3 Earnings: A Look at Key Metrics

Although the revenue and EPS for Bunge Global (BG) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Bunge Global Q3 Net Income Surges; Backs 2026 Earnings Guidance

(RTTNews) - Bunge Global SA (BG), an agribusiness, food processing, and grain trading company, on Thursday reported a surge in net income for the third quarter of fiscal 2026...

Bunge Global (BG) Q3 Earnings and Revenues Beat Estimates

Bunge Global (BG) delivered earnings and revenue surprises of +4.49% and +3.15%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Bunge Reports Third Quarter 2026 Results

Bunge Global SA (NYSE: BG) today reported third quarter 2026 results. Q3 GAAP diluted EPS from continuing operations of $1.64 vs. $0.86 in the prior year; $2.56 vs. $2.27 on an adjusted basis excluding certain gains/charges and mark-to-market timing differences Continued strong performance in...

Bunge Ready to Report Q3 Earnings: What's in Store for the Stock?

BG is set to report Q3 2026 earnings, with sales and profits expected to grow as the Viterra acquisition boosts processing capacity and global reach.

Bunge Global (BG) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Bunge Global (BG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Bunge World Food Day Volunteer Program Supports Food Security Around the World

Bunge Global SA (NYSE: BG), a premier agribusiness solutions company connecting farmers to consumers, today announced its annual World Food Day Global Volunteer Program, marking five years of community impact and collaboration. Throughout October, Bunge volunteers will join approximately 112 local...

Bunge Schedules Third Quarter 2026 Earnings Release and Conference Call

Bunge Global SA (NYSE: BG) will announce its results for the quarter ended Sept. 30, 2026, on Thursday, Oct. 29, 2026, prior to the market opening. Company management will also host a conference call at 7 a.m. Central Time to discuss the results. A slide presentation to accompany the discussion...

$BG Q3 &#39;26 Earnings Results &amp; Recap

Bunge maintained full-year 2026 adjusted EPS outlook at $9.25 to $9.75; Bunge expects 2026 adjusted annual effective tax rate of 23% to 25% and net interest expense of $640M.

Stocktwits

Bunge Ltd.

 Q3 '26 Earnings Results & Recap

Bunge maintained full-year 2026 adjusted EPS outlook at $9.25 to $9.75; Bunge expects 2026 adjusted annual effective tax rate of 23% to 25% and net interest expense of $640M.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Bunge maintained full-year 2026 adjusted EPS outlook at $9.25 to $9.75; Bunge expects 2026 adjusted annual effective tax rate of 23% to 25% and net interest expense of $640M.

Bunge's 2026 net interest expense range was revised to $640M; cash used for operations was $2.3B amid working-capital changes, while Tropical Oils results were lower amid trade disruptions and commissioning costs.

Bunge's soybean and softseed adjusted Segment EBIT exceeded prior-year figures; Bunge advanced Viterra-related synergies and began new oilseed-line production, while adjusted FFO was $2.01B versus $1.18B.

Bunge Global SA engages in agribusiness including food and ingredients. It operates through the following segments: Agribusiness, Refined & Specialty Oils, Milling, Sugar & Bioenergy, and Corporate & Other. The Agribusiness segment is an integrated, global business principally involved in the purchase, storage, transportation, processing and sale of agricultural commodities and commodity products. The Refined & Specialty Oils segment includes businesses that sell vegetable oils and fats, including cooking oils, shortenings, specialty ingredients, and renewable diesel feedstocks. The Milling segment refers to the businesses that sell wheat flours, bakery mixes, and corn-based products. The Sugar & Bioenergy segment consists of results from the company’s previously owned 50% ownership interest in BP Bunge Bioenergia. The Corporate & Other segment focuses on the salaries and overhead for corporate functions that are not allocated to individual reporting segments because the operating performance of such reporting segments is evaluated. It connects farmers to consumers to deliver essential and sustainable food, feed and fuel. The company was founded on February 14, 2023 and is headquartered in Chesterfield, MO.

Bunge Global SA

Tariff Cuts Are The ‘Single Most Possible Deliverable’ From Trump-Xi Talks, Says Jefferies: AI Chips, Rare Earths Relief Unlikely

Equity

Neutral Sentiment

<ul class="summary-bullets"><li>Jefferies called the proposed Board of Trade the “single most possible deliverable,” potentially opening the door to broader tariff reductions.</li><li>The firm added that Boeing and medical-device makers could benefit from renewed trade commitments.</li><li>It said agricultural and U.S. energy exporters could also see support.</li></ul>President Donald Trump and Chinese President Xi Jinping are set to meet Thursday, but Jefferies analysts said investors should not expect the talks to resolve two major market overhangs – AI chip export controls and rare-earth supplies.In a note to investors cited by Barrons, Jefferies said the “single most possible deliverable” from Thursday’s talks is the Trump administration’s plan for a Board of Trade to oversee reduced tariffs across a range of goods.The framework would extend the tariff-cutting approach the two countries have used since their meeting in Busan last October, when Trump reduced tariffs on Chinese imports to 47% from 57% in exchange for eased rare-earth restrictions and resumed soybean purchases.The meeting, Xi's first Washington visit in a decade, caps a week of preparatory talks between Treasury Secretary Scott Bessent, U.S. Trade Representative Jamieson Greer, and their Chinese counterparts covering trade, AI, and critical minerals.&nbsp;<h2 class="st-heading-2">Who Could Benefit From Trump-Xi Meeting?</h2>Jefferies flagged Boeing (BA) and medical-device makers as potential beneficiaries, pointing to recent comments from Greer as encouraging.&nbsp;<a href="https://stocktwits.com/symbol/BA">BA stock</a> edged 0.25% higher in pre-market trade on Wednesday. On Stocktwits, retail sentiment around the airplane manufacturer trended in ‘bullish’ territory over the past day.China had previously pledged to buy more than 200 Boeing aircraft and increase U.S. agricultural purchases by $17 billion annually under the May framework. Agricultural companies tied to soybean exports, including Archer-Daniels-Midland (ADM) and Bunge (BG), along with U.S. energy exporters, could also benefit if those commitments are reaffirmed.<a href="https://stocktwits.com/symbol/ADM">ADM stock</a> and&nbsp;<a href="https://stocktwits.com/symbol/BG">BG stock</a> edged around 0.20% higher in pre-market trade, while retail sentiment around both of them trended in ‘neutral’ territory over the past day.<h2 class="st-heading-2">AI Chips And Rare Earths Remain Off The Table</h2>Jefferies does not expect Thursday’s meeting to produce meaningful movement on semiconductors or rare earths, which remain closely tied to national-security concerns in both countries.That leaves chipmakers with significant China exposure, including Nvidia (NVDA), AMD (AMD) and Qualcomm (QCOM), without an expected catalyst from the talks. Rare-earth producer MP Materials (MP) is similarly outside Jefferies’ expected list of beneficiaries.<a href="https://stocktwits.com/symbol/NVDA">NVDA stock</a> traded flat in pre-market trade, while&nbsp;<a href="https://stocktwits.com/symbol/QCOM">QCOM</a> and&nbsp;<a href="https://stocktwits.com/symbol/AMD">AMD shares</a> edged 0.40% lower.&nbsp;<a href="https://stocktwits.com/symbol/MP">MP stock</a> edged around 0.12% higher.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-un-speech-us-president-signals-potential-iran-deal-after-midterms/cZMPrnJRBey">Trump UN Speech: US President Signals Potential Iran Deal After Midterms, But Also Urges Nations For Tehran’s Complete Economic Isolation</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Chinese President Xi Jinping and U.S. President Donald Trump attend a welcoming ceremony

The meeting is Chinese President Xi Jinping's first Washington visit in a decade and caps a week of preparatory talks.

Trump-Xi Talks May Bring Tariff Cuts, But AI Chips And Rare Earths Stay Off Table, Says Jefferies

The meeting is Chinese President Xi Jinping's first Washington visit in a decade and caps a week of preparatory talks. 

Advanced Micro Devices Inc

Boeing Co

MP Materials Corporation

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits Polls

$BG Bunge Global Daily Chart 
- Daily RSI is now oversold at 29 after the stock fell 23% since the Sept. high. 
- Price is sitting on trendline support. 
- Unusual activity on the $100 call for Jan. 15th 
- $144.10 is the average 1 year price target, implying 47%+ upside.

PeloSwing

$BG Q3 '26 Earnings Results & Recap

Bunge maintained full-year 2026 adjusted EPS outlook at $9.25 to $9.75; Bunge expects 2026 adjusted annual effective tax rate of 23% to 25% and net interest expense of $640M.

$BG  | Bunge Q3 2026 Earnings 
- Net Sales: $23.80B (est $23.38B) 
- Adj EPS: $2.56 (est $2.41) 
- Net Income: $318M 
- Still Sees FY Adj EPS: $9.25 To $9.75 (est $9.42) 
- Sees FY Net Interest Expenses: $640M To $670M (est $811.5M) 
- Sees FY Capex: $1.5B To $1.7B

Live Squawk

$BG is estimated to report earnings tomorrow before the open. I’m bullish heading into the report: BG has beaten EPS estimates in 7 of its last 8 reports, according to Stock Meadow.

john

$BG 
 
Grain moves by truck to the elevator, by rail to the port, and by ship to the customer. 
 
All three legs run on distillate, the middle cut of the barrel. 
 
A refinery outage in Russia becomes a logistics cost in the Midwest, with a lag measured in weeks.

Feed

News

Sentiment

Earnings

Fundamentals

Info

BG Bunge Ltd.

Fundamentals

Latest BG News